Lupus Research Alliance Response to Positive Trial Testing Obinutuzumab (Gazyva®) for Lupus Nephritis
NEW YORK, Nov. 10, 2019 /PRNewswire/ -- The Lupus Research Alliance (LRA) is pleased to acknowledge positive results presented by...
lupus research alliance
LRA Pleased to Share News of Lupus Nephritis Clinical Trial Launch
October 1, 2019
The Lupus Research Alliance is pleased to share news about the launch of EQUALISE, a Phase 1b...
Treat-to-Target is Feasible and Beneficial in Lupus
September 19, 2019
Treating patients with lupus until they reach specific health goals can reduce disease flares and prevent organ...
MOMENTOUS NEWS — Potential New Lupus Treatment Effectively Reduced Disease Activity in Phase III Trial
NEW YORK, NY. August 29 -- The Lupus Research Alliance is excited to share the good news that a...
PALS Clinical Trial Program Opens at Five Universities
August 8, 2019
In five pilot cities, people with lupus who are thinking about taking part in a clinical trial...
LRA-Funded Discovery May Benefit Alzheimer’s Disease
August 1, 2019
A new study by LRA Distinguished Innovator Award recipient Dr. Douglas Green of St. Jude Children’s Research...
LRA Partners with Celgene on Cutting-Edge Research Projects
August 1, 2019
The Lupus Research Alliance (LRA), the largest private funder of lupus research in the world, is very...
Dr. Daniel Wallace Appointed to Lupus Therapeutics Board
New York, NY, July 18, 2019 — Renowned Dr. Daniel Wallace joined the Lupus Research Alliance (LRA) affiliate Lupus Therapeutics Board of Directors. ...
Lupus Research Alliance and Lupus Therapeutics – Leading Voices in Trial Diversity
June 25, 2019
Caroline Donovan, Manager of Patient Engagement at Lupus Research Alliance (LRA) affiliate Lupus Therapeutics (LT) took part...
LRA’s 2019 Lupus Insight Prize Awarded to Dr. Ignacio Sanz
Boston, MA. June 19, 2019. The Lupus Research Alliance has awarded its 2019 Lupus Insight Prize to Ignacio Sanz,...
Gut Bacteria May Cause Antiphospholipid Syndrome, LRA-Funded Study Shows
June 18, 2019
A common type of bacteria living in the gut may spark a common lupus complication called antiphospholipid...
Lupus Research Alliance Pleased to Share Positive News about Potential Drug for Lupus Nephritis
NEW YORK, NY. June 11, 2019. The Lupus Research Alliance is pleased to share positive topline results from a...